European Journal of Gynaecological Oncology. 2026; 47(3): 134-134. doi: 10.22514/ejgo.2026.038
Correction

Correction: CpG methylation of the PAX1 promoter in exfoliated cervical cells: a potential cervical cancer screening model

Yu Chen1,†, Yuanyuan Zhang1,2,†, Xiaochun Chen1,†, Hong Chu1, Songqing Guan1, Qiuni Liang1, Yuting Xu1, Xinyue Lv1, Chunhua Li1, Yun Li3, Jin Liu1, Wenlan Liu3,*,, Zhiying Yu1,*,

1Department of Gynecology, Shenzhen Second People’s Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, 518035 Shenzhen, Guangdong, China

2Department of Obstetrics and Gynecology, the Affiliated Hospital of Guizhou Medical University, 550025 Guiyang, Guizhou, China

3The Center for Medical Genetics and Molecular Diagnosis, Shenzhen Second People’s Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, 518035 Shenzhen, Guangdong, China

*Corresponding Author(s):wlliu@szu.edu.cn (Wenlan Liu); 2011191208@email.szu.edu.cn (Zhiying Yu)

† These authors contributed equally.

History Published: 15 October 2026
Copyright:  ©2026 The Author(s). Published by MRE Press.
This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).

Collapse table of contents

Abstract

No abstract available.

Keywords:None.
PDF(247.35 kB)|EndNote (RIS)|BibTeX|RefMan|RefWorks

Cite this article

Yu Chen, Yuanyuan Zhang, Xiaochun Chen, Hong Chu, Songqing Guan, Qiuni Liang, Yuting Xu, Xinyue Lv, Chunhua Li, Yun Li, Jin Liu, Wenlan Liu, Zhiying Yu. Correction: CpG methylation of the PAX1 promoter in exfoliated cervical cells: a potential cervical cancer screening model. European Journal of Gynaecological Oncology. 2026; 47(3): 134-134. doi: 10.22514/ejgo.2026.038

The authors wish to issue the following correction to the original article [1].

1. Informed Consent Statement

The original published article did not contain an explicit statement regarding informed consent. The authors hereby confirm that written informed consent was obtained from all participants prior to their involvement in the study.

Corrected Statement (to be added to the “Ethics Approval and Consent to Participate” section):

The study was approved by the Ethics Committee of the Shenzhen Second People’s Hospital (approval number: KS20190521002-FS2019052903) and registered in the Chinese Clinical Trial Registry (registration number: ChiCTR2000029231). Written informed consent was obtained from all participants included in the study.

2. Typographical Error in the Predictive Index Formula

In the original article, a typographical error appeared in the constant term of the predictive index formula. In Section 3.4: The constant term was incorrectly printed as −5.933.

Corrected Formula (Section 3.4):

Predictive index = −5.993 + 15.211 × X21705687 + 7.890 × X21706427 + 1.846 × HPV16/18 (1,0) + 1.821 × other hr-HPV (1,0).

This correction is purely typographical and does not affect the statistical analysis, results, interpretations, or conclusions of the study.

The authors sincerely apologize for these oversights and any inconvenience caused to the readers and the journal.

References

Chen Y, Zhang YY, Chen XC, Chu H, Guan SQ, Liang QN, et al. CpG methylation of the PAX1 promoter in exfoliated cervical cells: a potential cervical cancer screening model. European Journal of Gynaecological Oncology. 2024; 45: 48–57.

[Google Scholar]